Asymmetric dimethylarginine (ADMA) as a novel independent risk factor for cardiovascular disease in haemodialysis patients

Abstrakt

Asymmetric dimethylarginine is independent of all other measured cardiovascular risk factors including homocysteine in hemodialysis patients.

Klíčová slova

• Asymmetric
• dimethylarginine
• novel
• independent
• factor
• cardiovascular
• disease
• haemodialysis
• patients